Multi-omics Analysis reveals novel therapeutic vulnerabilities in lung cancer

ABSTRACT: Non-small cell lung cancer (NSCLC) comprises the majority (~85%) of all lung tumors, with lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) being the most frequently diagnosed histological subtypes. Currently, multi-modal omics profiles had been carried out in NSCLC, but no studies reported yet a systems biology approach to provide a complete picture of molecular perturbations specifically for LUAD and LUSC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE159857 | GEO | 2022/05/04

REPOSITORIES: GEO